Pathway uncovered for greatest lupus genetic risk factor, study shows

The discovery could be a route to novel treatments for the autoimmune disease.

5:00 AM

Author | Noah Fromson

Microscope lab notes
Jacob Dwyer, Justine Ross, Michigan Medicine

Researchers at Michigan Medicine have uncovered the molecular mechanism that drives the disease-causing effects of the most common genetic risk factor for lupus, a study suggests.

Systemic lupus erythematosus is a common, incurable autoimmune disease that affects millions of individuals worldwide, with a particularly high prevalence among women. A genetic variant, called HLA-DRB1*03:01, is the greatest risk factor for the condition, which involves inflammation in many vital organs, and can lead to severe disability and death.

In a study recently published in communications biology (a Nature Portfolio journal), investigators found that a protein coded by that HLA variant triggers a cascade of molecular and cellular effects that can cause the inflammatory symptoms seen in lupus patients.

"For the first time, we have found the enigmatic mechanism that genetically predisposes people to the worst effects of the most typical form of lupus," said Joseph Holoshitz, M.D., senior author of the paper and professor of internal medicine and rheumatology at University of Michigan Medical School. "The findings could potentially facilitate the discovery of safe, simple and effective treatments for SLE by targeting this new pathway."

The results support a novel theory how genetic variants of the kind of HLA-DRB1*03:01 can lead to autoimmune diseases independent of antigen presentation, the traditionally studied mechanism, which has been long proposed but, so far, not directly proven.

"We have identified a chain of events in cell culture, as well as a mouse model of the disease, that demonstrate how the abnormalities that can cause lupus develop from the first effect of the risk gene, to signaling, all the way to immune abnormalities and clinical manifestations of lupus," said Bruna Miglioranza Scavuzzi, Ph.D., first author of the paper and a postdoctoral research fellow in the Division of Rheumatology at the University of Michigan Medical School.

The findings of this study are reminiscent of previous findings in rheumatoid arthritis, another HLA-associated disease, that have paved the way for the development of small molecules to effectively treat arthritis in mice, Holoshitz says.

"Human trials in RA with those compounds are being carried out, and I hope that our novel findings will lead to similar efforts to ease the burden of millions of lupus patients as well," he said.

Additional authors include Vincent van Drongelen, Ph.D., Bhavneet Kaur, Ph.D., Jennifer Callahan Fox, M.S., Jianhua Liu, Ph.D., Raquel A. Mesquita-Ferrari, Ph.D., J. Michelle Kahlenberg, M.D., Ph.D., Amr H. Sawalha, M.D., Evan A. Farkash, M.D., all of Michigan Medicine, Fernando Benavides, Ph.D., MD Anderson Cancer Center, Frederick W. Miller, M.D., Ph.D., National Institute of Environmental Health Sciences, Amr H. Sawalha, University of Pittsburgh.

Paper cited: "The lupus susceptibility allele DRB1*03:01 encodes a disease-driving epitope," communications biology. DOI: 10.1038/s42003-022-03717-x


More Articles About: Lab Notes Lupus Genetics Basic Science and Laboratory Research Rheumatology
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of health care news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories man holding cat in michigan sweater
Health Lab
Inside antiphospholipid syndrome: a patient's personal health journey
Antiphospholipid syndrome can cause many complications in the body making daily tasks difficult. With comprehensive medical care at University of Michigan Health, one patient is taking control of his diagnosis.
3 staff members holding up happy 20th wedding anniversary sign to patient in bed
Health Lab
A scleroderma clinical trial brings a better quality of life for one participant
The CAR-T treatment has been used in cancer patients for years. Now the approach is being used for those with severe scleroderma to teach the body to fight the autoimmune disorder.
stethoscope blue yellow
Health Lab
Researchers uncover novel mechanism that leads to high blood pressure
Researchers at Michigan Medicine have uncovered a key mechanism that regulates blood pressure and vascular remodeling in people with a genetic variant linked to high blood pressure.
purple white
Health Lab
Study defines key driver of aggressive ovarian cancer
A study explains the genetic underpinnings of a rare and aggressive form of ovarian cancer – and offers a potential pathway for new treatments.
cells purple some lighter cells in white
Health Lab
Researchers find early driver of prostate cancer aggressiveness
University of Michigan Health Rogel Cancer Center scientists identified a gene that plays a key role in prostate cancer cells that have transitioned to a more aggressive, treatment-resistant form. The gene can be indirectly targeted with an existing class of drugs, suggesting a potential treatment strategy for patients with aggressive subtypes of prostate cancer.
cancer cell drawing in blue ink on off white background with floating yellow dots two of them
Health Lab
Researchers engineer a herpes virus to turn on T cells for immunotherapy
The University of Michigan team identified herpesvirus saimiri, which infects the T cells of squirrel monkeys, as a source of proteins that activate pathways in T cells that are needed to promote T cell survival.